- Home
- NCRA vs PSTV Comparison
NCRA vs PSTV Comparison
Compare NCRA & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- PSTV
- Stock Information
- Founded
- NCRA 2002
- PSTV 1996
- Country
- NCRA Taiwan
- PSTV United States
- Employees
- NCRA N/A
- PSTV N/A
- Industry
- NCRA Farming/Seeds/Milling
- PSTV Medical/Dental Instruments
- Sector
- NCRA Consumer Staples
- PSTV Health Care
- Exchange
- NCRA Nasdaq
- PSTV Nasdaq
- Market Cap
- NCRA 15.1M
- PSTV 17.0M
- IPO Year
- NCRA N/A
- PSTV N/A
- Fundamental
- Price
- NCRA $1.55
- PSTV $0.49
- Analyst Decision
- NCRA
- PSTV Strong Buy
- Analyst Count
- NCRA 0
- PSTV 4
- Target Price
- NCRA N/A
- PSTV $8.88
- AVG Volume (30 Days)
- NCRA 33.6K
- PSTV 14.8M
- Earning Date
- NCRA 08-14-2025
- PSTV 08-14-2025
- Dividend Yield
- NCRA N/A
- PSTV N/A
- EPS Growth
- NCRA N/A
- PSTV N/A
- EPS
- NCRA N/A
- PSTV N/A
- Revenue
- NCRA $13,865,984.00
- PSTV $5,317,000.00
- Revenue This Year
- NCRA N/A
- PSTV $8.26
- Revenue Next Year
- NCRA N/A
- PSTV $8.39
- P/E Ratio
- NCRA N/A
- PSTV N/A
- Revenue Growth
- NCRA N/A
- PSTV N/A
- 52 Week Low
- NCRA $0.70
- PSTV $0.16
- 52 Week High
- NCRA $2.09
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- NCRA 53.23
- PSTV 45.83
- Support Level
- NCRA $1.56
- PSTV $0.45
- Resistance Level
- NCRA $1.67
- PSTV $0.65
- Average True Range (ATR)
- NCRA 0.09
- PSTV 0.11
- MACD
- NCRA -0.03
- PSTV -0.03
- Stochastic Oscillator
- NCRA 33.22
- PSTV 7.93
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).